The FDA cleared Apple Watch’s hypertension notification feature, which became available to users in October 2025. The feature, validated through clinical studies involving over 100,000 participants, represents the agency’s growing comfort with consumer wearables in clinical applications, even though it identifies only about 40% of people with hypertension. Over 75% of consumers now use healthcare apps or wearable devices to monitor their health, according to recent studies.
A Wyoming clinic’s successful implementation of remote blood pressure monitoring exemplifies wearables’ clinical potential. To provide remote monitoring for high-risk pregnancies, addressing a critical need for patients traveling hours to reach specialty care. The system uses connected blood pressure cuffs that automatically transmit readings to healthcare apps, where dedicated care managers monitor patients 24/7 and alert physicians when concerning trends emerge. This model particularly benefits rural areas where patients face significant travel barriers to routine monitoring.
【MORE】